Approval · Notice of Compliance 23413 · 2020
IBUPROFEN CAPLETS: Notice of Compliance 23413
Issued April 3, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23413
- Date
- April 3, 2020
- Company
- Vita Health Products Inc.Winnipeg, Manitoba, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates to comply with the plain language labelling regulations
- Canadian reference product
- ADVIL CAPLETS, ADVIL EXTRA STRENGTH CAPLETS, ADVIL TABLETS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN CAPLETS | Not yet assigned | — |
| IBUPROFEN EXTRA STRENGTH CAPLETS | Not yet assigned | — |
| IBUPROFEN TABLETS | Not yet assigned | — |